Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-115094
Filing Date
2024-11-07
Accepted
2024-11-07 08:53:47
Documents
6
Effectiveness Date
2024-11-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2427188d1_s8.htm S-8 77339
2 EXHIBIT 5.1 tm2427188d1_ex5-1.htm EX-5.1 8455
3 EXHIBIT 10.2 tm2427188d1_ex10-2.htm EX-10.2 120275
4 EXHIBIT 23.1 tm2427188d1_ex23-1.htm EX-23.1 1974
5 EX-FILING FEES tm2427188d1_ex-filingfees.htm EX-FILING FEES 20269
6 GRAPHIC tm2427188d1_ex5-1img01.jpg GRAPHIC 13450
  Complete submission text file 0001104659-24-115094.txt   248009
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283051 | Film No.: 241433417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)